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Like You’ve Never Seen Before
New methods to ‘see’ unstudied types of RNA reveal an incredibly
abundant regulatory molecule that plays a role in disease and health alike.
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BY EDYTA ZIELINSKA | ILLUSTRATION BY MONIKA JASNAUSKAITE

he human genome project, a race
to map out the code of human life,
was supposed to uncover untold secrets of
human health and disease. But even before
the 15-year project was finished, researchers
began to realize that there was much more
to understanding life than the string of
genes that coded for proteins. How did the
cell decide how much of each gene to
produce, and when? It became clear that
knowing when to turn specific genes on or
off could mean the difference between
health and diseases like cancer, Alzheimer’s
and many others.
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In the 1990s, researchers discovered
microRNAs, very short sequences (about 22
nucleotides) that came from the region of
DNA in between protein-coding genes.
These tiny molecules, researchers soon
found, were master regulators, fine-tuning
the cell’s genetic production. The work
opened a new field looking at the cell’s
RNA-regulators, all sped by a tool called
RNA-seq that could rapidly detect and
decode these novel microRNAs.
That tool, however, was limited to detecting
RNA types with a specific, but common,
sequence on their tails. In the past few
years, Yohei Kirino, PhD, and colleagues
developed a new set of tools and modified
old ones in order to detect the previously
un-seeable world of small RNAs. These
tools have revealed the properties of these
RNAs, where they come from and how
they may regulate health and disease.
A number of these new RNA molecules are
fragments of other well-known RNA
species, such as ribosomal RNA, messenger
RNA and transfer RNA, and contain a cyclic
phosphate (cP) tag at their end — a different
“tail” than microRNAs. Researchers had
known of these fragments, but assumed
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they were simply junk — chopped up pieces
meant for the cell’s recycler.
In 2015 and ‘16, Dr. Kirino’s lab published the
method to detect these cP-containing RNAs
(cP-RNAs). It was simple enough: add a
processing step to remove the cP tag from
cP-RNAs, before running the usual
RNA-seq. With this tool that they called
cP-RNA-seq, the researchers began to see just
how active these molecules really were.
The cP-RNAs, they showed, were involved in
hormone-dependent cancers like breast and
prostate cancers. Derived from transfer
RNAs (tRNAs), which normally deliver
building blocks to a growing protein chain,
these cP-RNAs were plentiful, especially in
hormone-driven cancers, and appeared to
promote cell replication, a key driver of
cancer growth.
Dr. Kirino and colleagues went on to find
other types of cP-RNA involved in unrelated
diseases, from neurodegeneration to
infection. During infection with
tuberculosis, for example, the researchers
found cP-RNA present at 1,000 times the
concentration as in healthy individuals.
What’s more, these cP-RNAs appeared to
act as a cytokine, spreading the alarm for
inflammation and immune activation.
Unlike cytokines, which are a chemical
signal, the cP-RNA would jump across
membranes within an exosome bubble
released from one cell and absorbed by
another. Once inside, they activate a
toll-like receptor,TLR-7, that detects and
responds to RNA molecules and activates
immune cells.
Most recently, the group discovered that
cP-RNAs were involved in helping maintain
genome integrity in sperm and egg cells.
They showed that cP-RNAs are the precur-
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sors to piRNA, a familiar and essential
molecule that silences jumping genes —
transposable elements — in these germline
cells. This silencing prevents jumping genes
from introducing mutations that can cause
harm or even kill the cell.
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“The Computational Medicine Center is
developing methods, computational and
experimental, for identifying different
classes of RNA and determining their
function. Dr. Kirino’s work uncovered an
intriguing class of RNA that had remained
‘invisible’ to standard sequencing approaches,” says Isidore Rigoutsos, PhD,
Richard W. Hevner Professor and Director
of the Computational Medicine Center.
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The Kirino group developed other tools to
see the unseen RNA world. They created
the YAMAT-seq, an efficient method for
sequencing tRNA, and the four-leaf clover
qRT-PCR to quantify these twisted
molecules; and the Dumbbell-PCR, a
method to quantify specific variants of
microRNA and other small RNAs.
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RNA Fragments in Health and Disease
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Messenger RNA (mRNA) are transcribed from DNA in
the nucleus and captured by ribosomes sitting on the
surface of the endoplasmic reticulum. Ribosomes read
the mRNA messages and attract transfer RNA (tRNA)
to build the protein components of life(1). But there are
many other types of RNA that are then converted into
RNA fragments called cP RNA. With the help of a new
tool called cP-RNA-seq and others, researchers can see
what these cP-RNA fragments are doing in the cell (2).
For example, these small RNA fragments are processed
further to become piRNA, which silence the jumping
genes that cause instability in sperm and egg cells (3);
they transfer between immune cells to activate immune
reactions to infectious disease (4); and their numbers
spike in hormone-dependent tumors like breast and
prostate cancer (5), possibly spurring aggressive disease.
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